CNS Disorders  >>  tenofovir disoproxil fumarate  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tenofovir disoproxil fumarate / Generic mfg.
NCT00624195: Clinical Trial of CNS-targeted HAART (CIT2)

Completed
2/3
59
US
FDA Approved Antiretroviral Therapy (see list below), Atripla, Combivir, Emtriva, Epivir, Epzicom, Retrovir, Trizivir, Truvada, Viread, Ziagen, Intelence, Rescriptor, Sustiva, Viramune, Agenerase, Aptivus, Invirase, Kaletra, Lexiva, Norvir, Prezista, Reyataz, Viracept, Fuzeon, Selzentry, Isentress
University of California, San Diego, National Institutes of Health (NIH), National Institute of Mental Health (NIMH)
HIV Infections
02/12
06/12

Download Options